We
have shown previously that the bleomycin (BLM) carbohydrate
moiety can recapitulate the tumor cell targeting effects of the entire
BLM molecule, that BLM itself is modular in nature consisting of a
DNA-cleaving aglycone which is delivered selectively to the interior
of tumor cells by its carbohydrate moiety, and that there are disaccharides
structurally related to the BLM disaccharide which are more efficient
than the natural disaccharide at tumor cell targeting/uptake. Because
BLM sugars can deliver molecular cargoes selectively to tumor cells,
and thus potentially form the basis for a novel antitumor strategy,
it seemed important to consider additional structural features capable
of affecting the efficiency of tumor cell recognition and delivery.
These included the effects of sugar polyvalency and net charge (at
physiological pH) on tumor cell recognition, internalization, and
trafficking. Since these parameters have been shown to affect cell
surface recognition, internalization, and distribution in other contexts,
this study has sought to define the effects of these structural features
on tumor cell recognition by bleomycin and its disaccharide. We demonstrate
that both can have a significant effect on tumor cell binding/internalization,
and present data which suggests that the metal ions normally bound
by bleomycin following clinical administration may significantly contribute
to the efficiency of tumor cell uptake, in addition to their characterized
function in DNA cleavage. A BLM disaccharide-Cy5** conjugate incorporating
the positively charged dipeptide d-Lys-d-Lys was
found to associate with both the mitochondria and the nuclear envelope
of DU145 cells, suggesting possible cellular targets for BLM disaccharide–cytotoxin
conjugates.